Form 4: Cadre Holdings Director Reports Stock Option Grant

Cadre Holdings, Inc. Director Mary E. Kissel reports the grant of stock options under the company's 2021 Stock Incentive Plan.

Summary

• Mary E. Kissel, a Director at Cadre Holdings, Inc. (CDRE), has reported the grant of stock options.
• The options are for the purchase of 17,393 shares of the Issuer's common stock.
• The exercise price for these options is $28.75 per share.
• The grant date for these options was June 16, 2026, with an expiration date of June 16, 2036.
• Vesting of the options is staggered: 4,349 shares vest on June 30, 2026, and subsequent tranches of 4,348 shares vest on September 30, 2026, December 31, 2026, and March 31, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard stock option grant to a director, which is a common compensation practice and does not inherently signal positive or negative performance.

Positives

• Director Mary E. Kissel has been granted stock options, indicating continued alignment of management and director interests with shareholders.
• The stock options have a long expiration date (June 16, 2036), providing a long-term incentive.
• The vesting schedule is phased, encouraging continued service and performance over several periods.

Risks

• The exercise price of $28.75 per share means the options will only be profitable if the stock price exceeds this level.
• If the company's stock price does not appreciate sufficiently, the granted options may not hold significant value.

Future Outlook

The filing itself does not contain forward-looking statements or guidance. It is a report of a stock option grant.

Industry Context

StockSavvy.ai notes that the granting of stock options to directors is a common practice across many industries, including security and defense services, to align executive and director compensation with shareholder value creation and to attract and retain talent.

Stakeholder Impact

• Shareholders: The grant of options aligns director incentives with potential future stock price appreciation, but also represents potential dilution if exercised.
• Employees: This filing is specific to a director and does not directly impact other employees, though it reflects the company's overall compensation strategy.
• Management: Reinforces the use of equity-based compensation as a tool for executive and director retention and motivation.

Next Steps

• The options will vest according to the schedule outlined: June 30, 2026; September 30, 2026; December 31, 2026; and March 31, 2027.
• Mary E. Kissel may exercise these options on or after their respective vesting dates, up to the expiration date of June 16, 2036.

Key Dates

Keywords

Cadre Holdings, CDRE, Form 4, Stock Options, Director Compensation, Equity Grant, SEC Filing, Insider Trading, Beneficial Ownership